Every founder who looks at medicine delivery in India finds the same wall within a week: you cannot just sell a strip of tablets the way you sell a bag of rice. Most treat the wall as a problem. I grew up on the other side of it, in a family pharmacy, and I think it is the product.
Here is what the rules actually say, in the order a clinic and a chemist meet them.
Schedule H: the prescription is not optional
The Drugs and Cosmetics Rules of 1945 put most prescription medicines in Schedule H. A Schedule H drug may be sold by retail only against the prescription of a registered medical practitioner, and the shop must hold a retail licence with a registered pharmacist on the premises. This is the rule behind every "please show the prescription" at the counter, and it is why a warehouse with no pharmacist cannot lawfully be the thing that hands you antibiotics.
Schedule H1: the register
In August 2013 the government carved a stricter list, Schedule H1, out of Schedule H: third- and fourth-generation antibiotics, anti-tuberculosis drugs and a set of habit-forming medicines, 46 at introduction. For these the chemist must keep a separate register with the prescriber's name and address, the patient's name, the drug and the quantity, and keep it for three years for inspection. Most shops keep this register by hand. It is the single most obvious thing software should do for a pharmacy, and almost none does.
The 2020 telemedicine guidelines: the digital prescription became real
On 25 March 2020, in the first week of the lockdown, the Board of Governors then running the Medical Council of India issued the Telemedicine Practice Guidelines as an appendix to the ethics regulations of 2002. They did three things that matter here.
They made a consultation over video, audio or text a legitimate medical consultation. They allowed the doctor to prescribe after it, for everything except a prohibited list: Schedule X drugs and narcotic or psychotropic substances under the NDPS Act, and medicines that need a physical examination first. And they said the doctor must give the patient a signed copy of the prescription, and may send it directly to a pharmacy if the patient explicitly consents.
That last sentence is the whole bridge between a clinic and a chemist. A prescription can now travel from the doctor's screen to the pharmacist's screen with the patient's permission, signed, without a photograph on WhatsApp in between.
What the lockdown added
The same month, the Health Ministry allowed retail licence holders to deliver medicines to the doorstep against a prescription received physically or by email, keeping Schedule H1, Schedule X and narcotics out of doorstep delivery. It was a pandemic measure, but it drew the line every delivery model has lived with since: the chemist delivers, against a prescription, with the stricter schedules handled at the counter.
The e-pharmacy rules that never came
In August 2018 the government published draft rules for e-pharmacies: registration with the central licensing authority, a pharmacist to verify every prescription, no narcotics or Schedule X. Eight years later they have not been notified; in July 2025 the government told the Rajya Sabha they remain under review. Courts in Delhi and Madras have gone back and forth on interim orders. Meanwhile the drug regulator's position from 2015 still holds: the Drugs and Cosmetics Act does not distinguish between a sale at the counter and a sale online. The same licence, the same pharmacist, the same prescription.
The rules do not forbid the phone. They insist on the pharmacist.
What this means for a clinic, and for a chemist
Read together, the rules describe a system that already exists on paper and almost nowhere in practice. The doctor consults, signs a digital prescription and sends it, with consent, to the pharmacy the patient already uses. The pharmacist reads it, checks it against the schedules, records the H1 sale in a register that fills itself, and hands the bag to a rider. The patient gets the medicine from the counter that knows them, in minutes, and every step has a name and a signature on it.
That is what MedMate is built to do: doctor e-prescriptions that land on the pharmacist's screen, the schedule check and the H1 register inside the billing software the shop already uses, and delivery from that shop. Nothing in the law needed changing for it. The gap was never regulation. It was software that treated the pharmacist as the point of the system instead of an obstacle to it.